FDA Inspection 1116043 — Lenox Hill Hospital

Lenox Hill Hospital — FEI 2470633

The FDA completed an inspection of Lenox Hill Hospital on December 13, 2019 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 13, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)